Strategic Response to an Outbreak of Circulating Vaccine-Derived Poliovirus Type 2-Syria, 2017-2018

被引：22

作者：

Mbaeyi, Chukwuma ^{[1
]}

Wadood, Zubair Mufti ^{[2
]}

Moran, Thomas ^{[2
]}

Ather, Fazal ^{[3
]}

Stehling-Ariza, Tasha ^{[4
]}

Nikulin, Joanna ^{[2
]}

Al Safadi, Mohammad ^{[2
]}

Iber, Jane ^{[5
]}

Zomahoun, Laurel ^{[1
]}

Abourshaid, Nidal ^{[6
]}

Pang, Hong ^{[5
]}

Collins, Nikki ^{[5
]}

Asghar, Humayun ^{[2
]}

Butt, Obaid ul Islam ^{[2
]}

Burns, Cara C. ^{[5
]}

Ehrhardt, Derek ^{[1
]}

Sharaf, Magdi ^{[2
]}

机构：

[1] CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA 30333 USA

[2] WHO, Polio Eradicat Dept, Geneva, Switzerland

[3] United Nations Childrens Fund, Middle East & North Africa Off, Amman, Jordan

[4] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA

[5] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA

[6] United Nations Childrens Fund, Syria Country Off, Damascus, Syria

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2018年 / 67卷 / 24期

关键词：

PROGRESS; ERADICATION; WORLDWIDE;

D O I：

10.15585/mmwr.mm6724a5

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

What is already known about this topic? Oral poliovirus vaccine (OPV) contains live attenuated viruses, which rarely revert to neurovirulence. These vaccine-derived polioviruses (VDPVs) tend to emerge in populations with low OPV coverage and are capable of causing paralysis. What is added by this report? In 2017, an outbreak of circulating VDPV type 2 (cVDPV2) occurred in Syria, causing 74 cases. Implementation of three rounds of monovalent OPV type 2 campaigns coupled with intensified surveillance interrupted the outbreak. What are the implications for public health practice? The outbreak in Syria underscores the risk for emergence of vaccine-derived polioviruses in settings of low OPV coverage. High-quality surveillance and targeted vaccination using monovalent OPV type 2 are effective in controlling cVDPV2 outbreaks. © 2018, Department of Health and Human Services. All Rights reserved.

引用

页码：690 / 694

页数：5

共 50 条

[11] Circulating vaccine-derived poliovirus type 2 outbreak 2024: the current public health concerns and management strategies
Rajbongshi, Anjon
Malaker, Suprety
Shandhi, Shoubeho S.
Islam, Md. R.
Dewan, Syed M. R.
INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 460 - 463
[12] An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China
Liang, Xiaofeng
Zhang, Yong
Xu, Wenbo
Wen, Ning
Zuo, Shuyan
Lee, Lisa A.
Yu, Jingjin
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (05): : 545 - 551
[13] Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018-2019
Zhao, Hehe
Ma, Xiaozhen
Tang, Haishu
Zhang, Yong
Chen, Na
Kaisaier, Wusiman
Wang, Qi
Wang, Cheng
Zhu, Shuangli
Qi, Qi
Liu, Yu
Ma, Qianli
Yang, Qing
Li, Junhan
Wang, Dongyan
Li, Xiaolei
Xiao, Jinbo
Zhu, Hui
Xu, Wenbo
Tong, Wenbin
Yan, Dongmei
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (12):
[14] Environmental surveillance of a circulating vaccine-derived poliovirus type 2 outbreak in Israel between 2022 and 2023:a genomic epidemiology study
Zuckerman, Neta S.
Bucris, Efrat
Morad-Eliyahu, Hagar
Weiss, Leah
Vasserman, Rinat
Fratty, Ilana S.
Aguvaev, Ira
Cohen-Said, Zvi
Matar, Rua
Erster, Oran
Shulman, Lester M.
Yishai, Ruth
Hecht-Sagie, Lior
Alroy-Preis, Sharon
Mendelson, Ella
Lustig, Yaniv
Sofer, Danit
Bar-Or, Itay
Weil, Merav
LANCET MICROBE, 2024, 5 (10):
[15] Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population
Wassilak, Steven
Pate, Muhammad Ali
Wannemuehler, Kathleen
Jenks, Julie
Burns, Cara
Chenoweth, Paul
Abanida, Emmanuel Ade
Adu, Festus
Baba, Marycelin
Gasasira, Alex
Iber, Jane
Mkanda, Pascal
Williams, A. J.
Shaw, Jing
Pallansch, Mark
Kew, Olen
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (07): : 898 - 909
[16] Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020 q
Darwar, Roopa
Biya, Oladayo
Greene, Sharon A.
Jorba, Jaume
Al Safadi, Mohammad
Franka, Richard
Wiesen, Eric
Durry, Elias
Pallansch, Mark A.
VACCINE, 2023, 41 : A25 - A34
[17] Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China
Yan, Dongmei
Zhang, Yong
Zhu, Shuangli
Chen, Na
Li, Xiaolei
Wang, Dongyan
Ma, Xiaozhen
Zhu, Hui
Tong, Wenbin
Xu, Wenbo
CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (07) : 1012 - 1018
[18] A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
Ayesheshem Ademe Tegegne
Atem Nathan Anyuon
George Awzenio Legge
Melisachew Adane Ferede
Zingbondo Isaac
Kirbak Anthony Laku
Sibhatu Biadgilign
Ochan Taban David Kilo
Fabian Ndenzako
Ndoutabe Modjirom
Olushayo Oluseun Olu
Sylvester Maleghemi
BMC Infectious Diseases, 23
[19] Impact of Supplementary Immunization Activities using Novel Oral Polio Vaccine Type 2 during a Large outbreak of Circulating Vaccine-Derived Poliovirus in Nigeria
Voorman, Arend
Lyons, Hil
Shuaib, Faisal
Adamu, Usman S.
Korir, Charles
Erbeto, Tesfaye
Bandyopadhyay, Ananda S.
Okiror, Samuel
JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (03): : 805 - 812
[20] Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024
Mendes, Amalia
Mohamed, Gedi Abdi
Derow, Mohamed
Stehling-Ariza, Tasha
Mohamed, Abdinoor
Mengistu, Kumlachew
Bullard, Kelley
Akbar, Irfan Elahi
Shukla, Hemant
Al Safadi, Mohammad
Martinez, Maureen
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2024, 73 (25): : 575 - 580

← 1 2 3 4 5 →